Bone Loss: Clinical Trials

5 trials for Bone Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Socket Preservation Using Dentin Graft Autogenous Dentin Graft With Collagen Sponge on Dental Implant Stability AUTOGENOUS TOOTH GRAFT WITH COLLAGEN SPONGE ON DENTAL IMPLANT STABILITY
Demineralized freeze dried allograft with collagen sponge, autogenous dentin graft with collagen sponge - Bone Loss, Bone Remodeling Disorder
Phase 3CompletedFaculty of Dental Medicine for Girls162023-09-152025-03-03
Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
Romosozumab Prefilled Syringe, Placebo, Zoledronic acid 5 mg - Bone Density, Low, Bone Loss
Phase 3CompletedKaren Klahr Miller, MD302021-09-202025-12-16
Simplified vs Conventional Drilling Protocol for Implant Placment
Conventional, simplfied - MBL, Bone Loss
Phase 3CompletedUniversidad Católica San Antonio de Murcia462020-12-012025-01-17
Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
Denosumab 60 MG [Prolia], Placebo Injection, Alendronate 70Mg Tab - Bone Density, Bone Loss
Phase 3CompletedMassachusetts General Hospital302017-10-252025-11-04
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Zoledronic acid, Letrozole - Bone Loss, Breast Cancer
Phase 3CompletedNovartis Pharmaceuticals10652003-05-012012-04-16

Narrower conditions

Bone Diseases, Metabolic (5)  ·  Anorexia Nervosa (2)  ·  Feeding and Eating Disorders (2)  ·  Bone Resorption (1)  ·  Breast Neoplasms (1)

Broader conditions

Bone Diseases (5)  ·  Metabolic Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Mental Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Zoledronic Acid (2)  ·  Alendronate (1)  ·  Congresses as Topic (1)  ·  Denosumab (1)  ·  Letrozole (1)

Sponsors

Faculty of Dental Medicine for Girls (1)  ·  Karen Klahr Miller, MD (1)  ·  Massachusetts General Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  Universidad Católica San Antonio de Murcia (1)

Countries

Egypt (2)  ·  Spain (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Guatemala (1)

Top investigators

Karen K Miller, MD (1)

Results publications

PMID 23047045, PMID 38979716